NEWS

"   Circle Culture
Feb 17 - 02

Casebia Therapeutics

Cc in charge for the the brand & corporate identity

We at Cc are very delighted to be involved in a brand building project for an avantgarde life science start up from Boston that has the mission to leverage the revolutionary technology called CRISPR/Cas 9. Fast Company declared CRISPR/Cas 9 as the next great innovation in biotech:   https://www.fastcompany.com/3054912/bayer-partners-with-gene-editing-startup-crispr-to-develop-new-drugs                                                         Casebia Therapeutics (www.casebia.com) is a novel joint venture between Bayer and CRISPR Therapeutics, focused on discovering, developing and commercializing new CRISPR/Cas9-based breakthrough therapeutics to treat blood disorders, blindness, and heart disease. Formed in the first quarter of 2016, the company began operations in the U.S. in August of 2016. Casebia has access to gene-editing technology from CRISPR Therapeutics in specific disease areas, as well as access to protein engineering expertise and relevant disease know-how through Bayer.
"  Circle Culture
JAN 17 - 02

Welcome Nike Sportswear

We are delighted to announce a new research project for Nike Sportswear Germany

"   Circle Culture  Circle Culture
Feb 17 - 01

Cc's cultural engagement

COME ALIVE! Circle Culture Gallery presents an exhibition in the spirit of Corita Kent.

Admired by Charles and Ray Eames, Alfred Hitchcock and Saul Bass, Corita Kent (1918–1986) was one of the most innovative and unusual pop artists of the 1960s, battling the political and religious establishments, revolutionizing graphic design and encouraging the creativity of thousands of people – all while living and practicing as a Catholic nun in California. Mixing advertising slogans and poetry in her prints and commandeering nuns and students to help make ambitious installations, processions and banners, Corita’s work is now recognized as some of the most striking – and joyful – American art of the 60s. With the exhibition "COME ALIVE!“, Circle Culture Gallery presents Coritas work in dialogue with statements by contemporary artists Stefan Strumbel, Katrin Fridriks, Aaron Rose and Adrian Falkner, who refer back to Coritas artistic spirit. Affiliated to Circle Culture Gallery, we are highly inspired by Coritas artistic approach that could hardly be more topical today. It is our strong belief that 'out of the box‘-thinking, teamwork and a courageous attitude are crucial skills for innovation processes. Join us for the exhibition opening on February 8, 7 – 10 pm @ REBELLE Pop-Up Space, Neuer Wall 72, 20354 Hamburg. Cc is proud to support the exhibition.
"Woman standing in front of a DNA, which looks like a supermarket shelf. Soon it is possible to buy products based on a DNA sequency  Circle Culture
JAN 17 - 01

DNA SEQUENCING

Do we buy DNA based products soon?

When we think of DNA sequencing we have a very complicated and expensive method in mind. You might think of Steve Jobs, who had his DNA deciphered in order to get insights into potential treatments and customized drug regimen – for this achievement he paid $100,000 five years ago. Today that same kind of sequencing costs just around one thousand dollar and is widely available. The company most responsible for revolutionizing the access to DNA is Illumina, a company that have sequenced some 90% of all the DNA data ever processed. Now, it’s new spin-off company “Helix” takes it to the next level and promises to take the science far beyond its initial uses. The company has begun to partner with labs, clinics, and consumer brands to identify and create novel products based on genetic information. Helix is taking DNA sequencing out of the lab and into the hands of consumers. Customers will be able to explore a host of DNA-enabled products and get valuable insights into their health, ancestry, nutrition, fitness, lifestyle, and more. From personalized fitness plans to family planning resources and even wine tasting recommendations: it seems as if there is a next wave of genomics on the rise. Cc is analysing this upcoming new market deeply, as we are involved in life science projects in Germany and the United States.